Semler Scientific Q3 2022 Earnings Report
Key Takeaways
Semler Scientific reported its Q3 2022 financial results, with revenue remaining unchanged at $14.0 million compared to the corresponding period of 2021. Net income was $3.7 million, a decrease of $0.5 million, or 11%, compared to $4.2 million. The company's cash and cash equivalents increased to $45.5 million.
Revenue was $14.0 million, same as the prior year period
Net income was $3.7 million, compared to $4.2 million
Cash and cash equivalents increased to $45.5 million from $35.9 million
Guidance has been updated for both revenues and operating expenses, such that the net result is to raise expected income from operations
Semler Scientific
Semler Scientific
Forward Guidance
Semler Scientific has updated its guidance for annual revenues and operating expenses for the year ending December 31, 2022. The net effect of these changes to guidance of revenues and operating expenses is that Semler Scientific expects income from operations will range from $16.7 million to $17.7 million.
Positive Outlook
- Revenue will range from $55.5 million to $58.0 million, representing a growth rate of 5% to 10%.
- Operating expenses will range from $38.8 million to $40.3 million, below the prior guidance of $42.5 million to $44.0 million.
- The guidance for operating expenses indicates less spending than previously anticipated due to greater expense management to be achieved during 2022.